1. Signaling Pathways
  2. GPCR/G Protein
  3. Vasopressin Receptor
  4. Vasopressin Receptor Isoform
  5. Vasopressin Receptor Inhibitor

Vasopressin Receptor Inhibitor

Vasopressin Receptor Inhibitors (6):

Cat. No. Product Name Effect Purity
  • HY-P0041A
    F992 TFA
    Inhibitor 98.19%
    F992 TFA is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue.
  • HY-W583271
    Zn(II) Deuteroporphyrin IX 2,4 bis ethylene glycol
    Inhibitor
    Zn(II) Deuteroporphyrin IX 2,4 bis ethylene glycol is a heme oxygenase (HO) inhibitor, and inhibiting HO activity can reduce the release of hypothalamic hormones like AVP, OT, and ANP caused by hyperosmolarity. Zn(II) Deuteroporphyrin IX 2,4 bis ethylene glycol can be used for research on hyperbilirubinemia.
  • HY-105652
    Ambucetamide
    Inhibitor
    Ambucetamide is an antispasmodic agent. Ambucetamide alleviates menstrual pain.
  • HY-P0041
    F992
    Inhibitor
    F992 is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue.
  • HY-B0662A
    Imidafenacin hydrochloride
    Inhibitor
    Imidafenacin (KRP-197; ONO-8025) hydrochloride is an orally active inhibitor of muscarinic (mAChR) M1 and M3 receptors. Imidafenacin hydrochloride potently inhibits bladder contraction in vivo and exerts an antidiuretic effect by enhancing the signaling pathway of vasopressin (antidiuretic hormone). Imidafenacin hydrochloride can be used in research related to overactive bladder.
  • HY-P10046
    [Deamino-Pen1,Val4,D-Arg8]-vasopressin
    Inhibitor
    [Deamino-Pen1,Val4,D-Arg8]-vasopressin (AVP-A) is an arginine-vasopressin (AVP) antagonist. AVP-A can significantly lower plasma aldosterone concentration in rats. AVP-A can be used for the research of the growth and steroidogenic capacity of rat adrenal zona glomerulosa.